Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Lancet
; 380(9855): 1749-58, 2012 Nov 17.
Article
in En
| MEDLINE
| ID: mdl-23036896
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrazoles
/
Pyridones
/
Warfarin
/
Stroke
/
Hemorrhage
/
Anticoagulants
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Lancet
Year:
2012
Type:
Article
Affiliation country:
United States